Organogenesis Holdings Inc. (ORGO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 200M 400M 600M Q3 '17: 145.4M Q4 '17: 198.5M Q1 '18: 194.2M Q2 '18: 183.7M Q3 '18: 183M Q4 '18: 193.4M Q1 '19: 215M Q2 '19: 236.4M Q3 '19: 249.9M Q4 '19: 261M Q1 '20: 265.6M Q2 '20: 269.6M Q3 '20: 306.1M Q4 '20: 338.3M Q1 '21: 379.1M Q2 '21: 433.4M Q3 '21: 446.3M Q4 '21: 467.4M Q1 '22: 461.9M Q2 '22: 460.1M Q3 '22: 463.2M Q4 '22: 450.9M Q1 '23: 461.4M Q2 '23: 457.3M Q3 '23: 449M Q4 '23: 433.1M Q1 '24: 435.5M Q2 '24: 448.4M Q3 '24: 455M Q4 '24: 482M Q1 '25: 458.8M Q2 '25: 429.5M Q3 '25: 465.2M Q4 '25: 564.2M Q1 '26: 514.7M Q2 '26: 457.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 150M 300M 450M Q4 '17: 137.3M Q1 '18: 131.8M Q2 '18: 119.4M Q3 '18: 115.3M Q4 '18: 124.6M Q1 '19: 143.8M Q2 '19: 163M Q3 '19: 176.9M Q4 '19: 185M Q1 '20: 187.8M Q2 '20: 191.2M Q3 '20: 223.9M Q4 '20: 251M Q1 '21: 285.1M Q2 '21: 329.4M Q3 '21: 339.2M Q4 '21: 353.2M Q1 '22: 348.1M Q2 '22: 349.6M Q3 '22: 352.7M Q4 '22: 345.9M Q1 '23: 354.9M Q2 '23: 351.1M Q3 '23: 343.2M Q4 '23: 326.7M Q1 '24: 326.9M Q2 '24: 336.9M Q3 '24: 342.6M Q4 '24: 366.3M Q1 '25: 348M Q1 '18 Q1 '19 Q1 '20 Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25

Operating Income TTM

-60M -30M 0 30M 60M 90M Q4 '16: -1.3M Q1 '17: -1.5M Q2 '17: -1.8M Q3 '17: -4.6M Q4 '17: -5.7M Q1 '18: -25.5M Q2 '18: -42.3M Q3 '18: -49.5M Q4 '18: -51.6M Q1 '19: -43.7M Q2 '19: -34M Q3 '19: -32.2M Q4 '19: -29.9M Q1 '20: -32.8M Q2 '20: -27.8M Q3 '20: 3.3M Q4 '20: 27.1M Q1 '21: 54.8M Q2 '21: 80.6M Q3 '21: 74.1M Q4 '21: 72.2M Q1 '22: 59.5M Q2 '22: 47.8M Q3 '22: 33.3M Q4 '22: 22.3M Q1 '23: 18.4M Q2 '23: 16.2M Q3 '23: 22.5M Q4 '23: 12.5M Q1 '24: 12.7M Q2 '24: -11M Q3 '24: -12.8M Q4 '24: -1.3M Q1 '25: -24.2M Q2 '25: -22.9M Q3 '25: -8.4M Q4 '25: 44.7M Q1 '26: 2.5M Q2 '26: -35.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-105M -70M -35M 0 35M 70M 105M Q4 '16: -208.7K Q1 '17: -52.3K Q2 '17: 328.5K Q3 '17: -1.8M Q4 '17: -6M Q1 '18: -28.7M Q2 '18: -28.7M Q3 '18: -39.6M Q4 '18: -44.5M Q1 '19: -37.6M Q2 '19: -47.6M Q3 '19: -45.3M Q4 '19: -38.7M Q1 '20: -39.4M Q2 '20: -34.9M Q3 '20: -3.4M Q4 '20: 17.1M Q1 '21: 43.3M Q2 '21: 69.2M Q3 '21: 61M Q4 '21: 94.2M Q1 '22: 83.3M Q2 '22: 71.4M Q3 '22: 59M Q4 '22: 15.5M Q1 '23: 13.5M Q2 '23: 10M Q3 '23: 13M Q4 '23: 4.9M Q1 '24: 5.8M Q2 '24: -16.5M Q3 '24: -7.4M Q4 '24: 861K Q1 '25: -15.9M Q2 '25: -8.2M Q3 '25: 1M Q4 '25: 37M Q1 '26: 2.7M Q2 '26: -84.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 60M 120M 180M Q4 '17: 142.8M Q1 '18: 154.3M Q2 '18: 161.4M Q3 '18: 164.8M Q4 '18: 176.2M Q1 '19: 152.2M Q2 '19: 128.4M Q3 '19: 106.1M Q4 '19: 75.9M Q1 '20: 77.8M Q2 '20: 78.4M Q3 '20: 82.2M Q4 '20: 87.3M Q1 '21: 94M Q2 '21: 103.9M Q3 '21: 107.1M Q4 '21: 114.2M Q1 '22: 113.8M Q2 '22: 110.5M Q3 '22: 110.5M Q4 '22: 105M Q1 '23: 106.5M Q2 '23: 106.2M Q3 '23: 105.8M Q4 '23: 106.5M Q1 '24: 108.6M Q2 '24: 111.5M Q3 '24: 112.5M Q4 '24: 115.7M Q1 '25: 110.8M Q2 '25: 109.2M Q3 '25: 118.7M Q4 '25: 137.5M Q1 '26: 139.6M Q2 '26: 135.6M Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q3 '17: -5.3M Q4 '17: -3.5M Q1 '18: -7.8M Q2 '18: -23.4M Q3 '18: -46.2M Q4 '18: -60.6M Q1 '19: -65.7M Q2 '19: -62.1M Q3 '19: -44.5M Q4 '19: -33.5M Q1 '20: -41.3M Q2 '20: -38.5M Q3 '20: -24.1M Q4 '20: 5.5M Q1 '21: 21.4M Q2 '21: 48.3M Q3 '21: 67.2M Q4 '21: 62M Q1 '22: 64.7M Q2 '22: 57.4M Q3 '22: 35M Q4 '22: 24.9M Q1 '23: 18.4M Q2 '23: 16.8M Q3 '23: 28.1M Q4 '23: 30.9M Q1 '24: 25.8M Q2 '24: 21.9M Q3 '24: 13.9M Q4 '24: 14.2M Q1 '25: 4.4M Q2 '25: -33.2M Q3 '25: -38.8M Q4 '25: -10.3M Q1 '26: 30.8M Q2 '26: 32M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-75M -50M -25M 0 25M 50M 75M Q4 '18: -62.5M Q1 '19: -67.8M Q2 '19: -64.6M Q3 '19: -47.4M Q4 '19: -39.5M Q1 '20: -51.2M Q2 '20: -49.6M Q3 '20: -39.9M Q4 '20: -12.2M Q1 '21: 3.1M Q2 '21: 27.7M Q3 '21: 35.8M Q4 '21: 30.8M Q1 '22: 31.8M Q2 '22: 22.6M Q3 '22: 6.5M Q4 '22: -9M Q1 '23: -16.4M Q2 '23: -19.3M Q3 '23: -3.6M Q4 '23: 6.6M Q1 '24: 6.8M Q2 '24: 8.5M Q3 '24: 3.9M Q4 '24: 4.2M Q1 '25: -7M Q2 '25: -46.4M Q3 '25: -51.7M Q4 '25: -24.5M Q1 '26: 17.1M Q2 '26: 20.8M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q1 '17: 66.7M Q2 '17: 64M Q3 '17: 64M Q4 '17: 64.1M Q3 '19: 92.3M Q1 '20: 104.5M Q2 '20: 104.7M Q3 '20: 108.5M Q1 '21: 133.5M Q2 '21: 134M Q3 '21: 133.9M Q1 '22: 128.8M Q2 '22: 132.6M Q3 '22: 132.2M Q1 '23: 131.1M Q2 '23: 133.1M Q3 '23: 133.4M Q1 '24: 131.9M Q2 '24: 132.6M Q3 '24: 133.9M Q1 '25: 126.3M Q2 '25: 126.9M Q3 '25: 130.8M Q1 '26: 127.8M Q2 '26: 128.7M Q1 '17 Q3 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.05 -0.70 -0.35 0.00 0.35 0.70 1.05 Q4 '16: -0.02 Q1 '18: -0.50 Q2 '18: -0.80 Q3 '18: -0.91 Q4 '18: -0.96 Q1 '19: -0.78 Q2 '19: -0.59 Q3 '19: -0.52 Q4 '19: -0.42 Q1 '20: -0.41 Q2 '20: -0.35 Q3 '20: -0.04 Q4 '20: 0.15 Q1 '21: 0.38 Q2 '21: 0.58 Q3 '21: 0.48 Q4 '21: 0.69 Q1 '22: 0.61 Q2 '22: 0.53 Q3 '22: 0.44 Q4 '22: 0.12 Q1 '23: 0.11 Q2 '23: 0.08 Q3 '23: 0.10 Q4 '23: 0.04 Q1 '24: 0.04 Q2 '24: -0.13 Q3 '24: -0.06 Q4 '24: -0.01 Q1 '25: -0.16 Q2 '25: -0.13 Q3 '25: -0.11 Q4 '25: 0.15 Q1 '26: -0.12 Q2 '26: -0.79 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.